Visalytics
Visalytics
approved EB-2 (NIW)

Clinical Fellow

Immunology · Jordan · 2025-03-04

Processing Time
64 days
Decision Date
2025-03-04
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research into the mechanistic contributions of T and B cells to the pathogenesis of immunodeficiency and immune dysregulation, aiming to identify and develop novel therapeutics for immunological diseases.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses the substantial burden of autoimmune and immune deficiency disorders on the U.S. healthcare system and supports public health outcomes.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 8 publications, 185 citations, and funding from the NIH and Perkin Fund demonstrates his capability and influence in the field.

3 Waiver Benefit to the US Met

The ongoing demand for the petitioner's specific expertise in immunodeficiency and his contributions to fundamental science and clinical approaches justify the waiver.

Why This Petition Was Approved

The petition was approved based on the petitioner's 8 peer-reviewed journal articles in top-tier journals, 185 citations, and funding from prestigious institutions like the NIH and the Perkin Fund. Additionally, two expert recommendation letters confirmed the ongoing demand for his expertise in addressing immunodeficiency resulting from cancer and chronic illness treatments.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Original Contributions

Similar Cases

Postdoctoral Researcher

Pharmaceuticals · Egypt

WeGreened EB-2 (NIW) approved
Tennessee 646 days 2025-11-14
The petitioner proposes to examine immune system dysfunction and its relationship to serious medical conditions to uncover novel immune-targeted treatment strategies. The work focuses on identifying immunological mechanisms that inform the development of new therapeutic strategies for autoimmune disorders, cardiovascular disease, and inflammatory conditions.
View Case

Research Scientist

Biotechnology · Slovenia

WeGreened EB-2 (NIW) approved
New York 64 days 2025-02-24
The petitioner proposes to advance the development of robust immunotherapies designed to overcome contemporary limitations such as impaired cell function and disease resistance. Her work focuses on elucidating novel molecular mechanisms of immune cells to improve patient outcomes in cancer care and autoimmune disease management.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Ohio 90 days 2025-01-24
The petitioner proposes to continue his research into the role of immune cells in human diseases, specifically focusing on autoimmunity and tumors. His work aims to develop novel immunotherapies for Diffuse Intrinsic Pontine Glioma (DIPG) and identify new therapeutic targets to improve treatments for cancer and autoimmune conditions.
View Case

Business Manager

Pharmaceuticals · China

WeGreened EB-2 (NIW) rfe approved
323 days 2025-06-16
The petitioner proposes to continue her research in the pharmaceutical industry focusing on precision medicine for autoimmune and inflammatory diseases. She utilizes multi-color flow cytometry and genetic variation analysis to identify immune pathways for the development of novel, personalized therapeutics for rare and severe immune-related conditions.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from Jordan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-04.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 64 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Jordan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist